Clinical efficacy and safety of high-dose imatinib for chronic myeloid leukemia patients: An updated meta-analysis
Journal Of Cancer Research And TherapeuticsPeer ReviewedPeng Wang +32016Journals
The aim of this study was to evaluate the clinical efficacy and safety of high-dose imatinib (IM) for chronic myeloid leukemia (CML) patients by pooled published studies.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support